Pfizer To Pay $785M To Settle FCA Claims Over Protonix
Law360, New York (February 16, 2016, 9:32 AM EST) -- Pfizer said Tuesday that it expects to pay $785 million to settle False Claims Act suits alleging its Wyeth unit overcharged Medicaid for heartburn drug Protonix, bringing a momentous end to whistleblower litigation over the program’s discount requirements.
The cases against Wyeth center on discounts it offered to hospitals for Protonix. The DOJ claimed the Pfizer unit violated Medicaid's "best price" provision by not offering the program those same discounts. (Credit: AP) New York-based Pfizer said it reached an “agreement in principle” to make the nine-figure payout in exchange for dismissal of two whistleblower suits that the U.S. Department of Justice...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!